PE  Merlin Nexus

     Office Locations:

424 West 33rd St., Suite 330
New York, NY 10001
Phone: 646-227-5270



  • Middle Market



  • Life Sciences & Healthcare



    Merlin Nexus is a company focused on crossover private equity investing in the life sciences industry. Merlin Nexus invests globally in private and public healthcare companies. With its first fund launched in 2001 by Dominique Semon, Merlin Nexus now has several crossover private equity funds and a public-only fund, with commitments totaling $200 million. The Merlin Nexus objective is to realize long-term capital appreciation from investments in: Late-stage private companies; PIPEs (Private Investments in Public Equity); and select, long-term, open market investments. Unlike venture capital funds, Merlin Nexus funds are distinguished by relatively high liquidity and by short, 5-year maturities. The firm targets for each private investment a potential for liquidity within 24 months after initial investment, as well as a 2-3 times return on invested capital.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Alberto Bianchinotti Chief Financial Officer
    Christian Richard Head of Research
    Dominique Semon Chief Investment Officer


    Portfolio companies include:

        web link

        web link

        web link

        web link

      Salient Surgical
        web link


    Recent News: